SingulOmics Corporation was established in 2016 in New York as a genomic research and service company specializing in the emerging field of single-cell omics. Building on the unmatched expertise in single-cell genomics, transcriptomics and epigenomics developed since mid-2000s at Albert Einstein College of Medicine, our mission is to develop and provide high-quality innovative single-cell services to academic and industrial communities around the world.

We are proud to offer:


Check out SingulOmics in the News: